Arama Sonuçları - Martin Priemer
- Gösterilen 1 - 3 sonuçlar arası kayıtlar. 3
-
1
Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels Yazar: Michael Blank, Toni Weinschenk, Martin Priemer, Hermann J. Schluesener
Baskı/Yayın Bilgisi 2001Artigo -
2
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL–positive leukemias identified by a proteomics approach Yazar: Stefan Balabanov, Artur Gontarewicz, Patrick Ziegler, Ulrike Hartmann, Winfried Kammer, Mhairi Copland, Ute Brassat, Martin Priemer, Ilona Hauber, Thomas Wilhelm, Gerold Schwarz, Lothar Kanz, Carsten Bokemeyer, Joachim Hauber, Tessa L. Holyoake, Alfred Nordheim, Tim H. Brümmendorf
Baskı/Yayın Bilgisi 2006Artigo -
3
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target Selection Yazar: Jens Fritsche, Barbara Rakitsch, Franziska Hoffgaard, Michael Römer, Heiko Schuster, Daniel J. Kowalewski, Martin Priemer, Vlatka Stos‐Zweifel, Helen Hörzer, Arun Satelli, Annika Sonntag, Valentina Goldfinger, Colette Song, Andrea Mahr, Martina Ott, Oliver Schoor, Toni Weinschenk
Baskı/Yayın Bilgisi 2018Artigo
Arama Araçları:
İlgili Konular
Biology
Computational biology
Immunology
ABL
Antigen
Aptamer
Biochemistry
Bioinformatics
Biophysics
Cancer
Cancer immunotherapy
Cancer research
Cell biology
Chemistry
Clinical trial
DNA
Genetics
Human leukocyte antigen
Imatinib
Imatinib mesylate
Immunotherapy
Internal medicine
K562 cells
Leukemia
Medicine
Molecular biology
Myeloid leukemia
Precision medicine
Signal transduction
Tyrosine kinase